Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Covington
Farmers Insurance
Queensland Health
Merck
AstraZeneca
Citi
Deloitte
Dow

Generated: May 21, 2018

DrugPatentWatch Database Preview

Monarch Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for MONARCH PHARMS, and what generic and branded alternatives to MONARCH PHARMS drugs are available?

MONARCH PHARMS has twenty-two approved drugs.



Summary for Monarch Pharms
US Patents:0
Tradenames:17
Ingredients:14
NDAs:22

Drugs and US Patents for Monarch Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Monarch Pharms THALITONE chlorthalidone TABLET;ORAL 088051-001 Nov 12, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Monarch Pharms PROCTOCORT hydrocortisone CREAM;TOPICAL 083011-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Monarch Pharms SEPTRA GRAPE sulfamethoxazole; trimethoprim SUSPENSION;ORAL 017598-002 Feb 12, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Monarch Pharms MENEST estrogens, esterified TABLET;ORAL 084950-001 Approved Prior to Jan 1, 1982 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Monarch Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Monarch Pharms SEPTRA DS sulfamethoxazole; trimethoprim TABLET;ORAL 017376-002 Approved Prior to Jan 1, 1982 4,209,513 ➤ Try a Free Trial
Monarch Pharms QUIBRON-T/SR theophylline TABLET, EXTENDED RELEASE;ORAL 087563-001 Jun 21, 1983 4,465,660 ➤ Try a Free Trial
Monarch Pharms SEPTRA sulfamethoxazole; trimethoprim TABLET;ORAL 017376-001 Approved Prior to Jan 1, 1982 4,209,513 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Colorcon
Teva
Express Scripts
Cerilliant
Deloitte
Citi
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.